Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217633 · ClinicalTrials.gov registry record · Phase 2
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
A Phase 2 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00217633 is a Phase 2 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 38 participants.
The verdict
NCT00217633, a Phase 2 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
This phase II trial is studying how well pelvic exenteration works in treating patients with recurrent cervical cancer. Pelvic exenteration may be effective in treating recurrent cervical cancer.
Interventions
- PROCEDURE Conventional Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217633
The ClinicalTrials.gov registry entry for NCT00217633 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Conventional Surgery is the first listed.
NCT00217633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217633 about?
NCT00217633 is a clinical study titled "Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer". This phase II trial is studying how well pelvic exenteration works in treating patients with recurrent cervical cancer. Pelvic exenteration may be effective in treating recurrent cervical cancer.
What is the current status of trial NCT00217633?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2006-01.
What interventions are being tested in trial NCT00217633?
The interventions under investigation include: Conventional Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00217633?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.